Literature DB >> 30489086

Proteomic Profiling of Human Hepatic Stellate Cell Line LX2 Responses to Irradiation and TGF-β1.

Baoying Yuan1, Yuhan Chen1,2, Zhifeng Wu1, Li Zhang1, Yuan Zhuang1, Xiaomei Zhao1, Hao Niu1, Jason Chia-Hsien Cheng3, Zhaochong Zeng1.   

Abstract

Hepatic stellate cells (HSCs) are the main target of radiation damage and primarily contribute to the development of radiation-induced liver fibrosis. However, the molecular events underlying the radiation-induced activation of HSCs are not fully elucidated. In the present study, human HSC line LX2 was treated with X-ray irradiation and/or TGF-β1, and profibrogenic molecules were evaluated. The iTRAQ LC-MS/MS technology was performed to identify global protein expression profiles in LX2 following exposure to different stimuli. Irradiation or TGF-β1 alone increased expression of α-SMA, collagen 1, CTGF, PAI-1, and fibronectin. Irradiation and TGF-β1 cooperatively induced expression of these profibrotic markers. In total, 102, 137, 155 dysregulated proteins were identified in LX2 cell samples affected by irradiation, TGF-β1, or cotreatment, respectively. Bioinformatic analyses showed that the three differentially expressed protein sets were commonly associated with cell cycle and protein processing in endoplasmic reticulum. The expression of a set of proteins was properly validated: CDC20, PRC1, KIF20A, CCNB1, SHCBP, TACC3 were upregulated upon irradiation or irradiation and TGF-β1 costimulation, whereas SPARC and THBS1 were elevated by TGF-β1 or TGF-β1 plus irradiation treatment. Furthermore, CDC20 inhibition suppressed expression of profibrotic markers in irradiated and TGF-β1-stimulated LX2 cells. Detailed data on potential molecular mechanisms causing the radiation-induced HSC activation presented here would be instrumental in developing radiotherapy strategies that minimize radiation-induced liver fibrosis.

Entities:  

Keywords:  hepatic fibrosis; hepatic stellate cell; iTRAQ; irradiation; proteomics

Mesh:

Substances:

Year:  2018        PMID: 30489086     DOI: 10.1021/acs.jproteome.8b00814

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  6 in total

Review 1.  Hepatic Stellate Cell: A Double-Edged Sword in the Liver.

Authors:  Nianan Luo; Jiangbin Li; Yu Wei; Jianguo Lu; Rui Dong
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

2.  Prophylactical Low Dose Whole-Liver Irradiation Inhibited Colorectal Liver Metastasis by Regulating Hepatic Niche in Mice.

Authors:  Lu Wang; Yinan Sun; Xiaoxiao Luo; Hu Han; Han Yin; Ben Zhao; Xinyi Chen; Qianqian Yu; Hong Qiu; Xianglin Yuan
Journal:  Onco Targets Ther       Date:  2020-08-24       Impact factor: 4.147

3.  Manipulating the Tumor Microenvironment in Tumor Organoids Induces Phenotypic Changes and Chemoresistance.

Authors:  Anthony Dominijanni; Mahesh Devarasetty; Shay Soker
Journal:  iScience       Date:  2020-11-23

4.  Identification and validation of long non-coding RNA associated ceRNAs in intrauterine adhesion.

Authors:  Jingni Zhang; Peng Jiang; Yuan Tu; Ning Li; Yuzhen Huang; Shan Jiang; Wei Kong; Rui Yuan
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

5.  Proteomic Changes of Activated Hepatic Stellate Cells.

Authors:  Maximilian Schinagl; Tamara Tomin; Juergen Gindlhuber; Sophie Honeder; Raphael Pfleger; Matthias Schittmayer; Michael Trauner; Ruth Birner-Gruenberger
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 6.208

6.  Kinsenoside Protects Against Radiation-Induced Liver Fibrosis via Downregulating Connective Tissue Growth Factor Through TGF-β1 Signaling.

Authors:  Xiaoqi Nie; Qianqian Yu; Long Li; Minxiao Yi; Bili Wu; Yongbiao Huang; Yonghui Zhang; Hu Han; Xianglin Yuan
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.